Shi-Zhe Zhang

机构：Ministry of Education of the People's Republic of China, Fudan University, Zhongshan Hospital

发表论文 9 篇 · 总被引 498 次 · h-index 8

代表论文

• miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a (2018 · Journal of Hematology & Oncology · 被引 241)
• PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma (2021 · Experimental Hematology and Oncology · 被引 97)
• NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma (2020 · Cell Death and Disease · 被引 59)
• The Rho GTPase Rnd1 inhibits epithelial–mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target (2018 · Cell Death and Disease · 被引 38)
• Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a (2018 · Journal of Hematology & Oncology · 被引 20)
• Irbesartan inhibits metastasis by interrupting the adherence of tumor cell to endothelial cell induced by angiotensin II in hepatocellular carcinoma (2021 · Annals of Translational Medicine · 被引 17)